Screening for cancer of the colon and rectum
DOI:
https://doi.org/10.32385/rpmgf.v19i5.9977Keywords:
Colon and Rectum Cancer, Screening, Evidence Based MedicineAbstract
Cancer of the colon and rectum (CRC) is the leading cause of morbidity and mortality from cancer in Portugal. The role of Primary Prevention is debated. Despite the controversy, some models show that screening for CRC is cost-effective compared with no screening, although there is no solid evidence to determine which test more effective or cost-effective. As important as the choice of the test is to increase adherence to screening. The screening of the CCR should be performed from the age of 50 with occult blood in the stool (FOBT) on an annual or biennial. This strategy reduces the incidence and mortality from CRC. In high-risk population screening should start early, after 40 years. Despite the benefits of screening, more information is needed about the potential damage, population adherence and costs of different tests before being widely applied.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
